propranolol has been researched along with Thyrotoxicosis in 101 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Thyrotoxicosis: A hypermetabolic syndrome caused by excess THYROID HORMONES which may come from endogenous or exogenous sources. The endogenous source of hormone may be thyroid HYPERPLASIA; THYROID NEOPLASMS; or hormone-producing extrathyroidal tissue. Thyrotoxicosis is characterized by NERVOUSNESS; TACHYCARDIA; FATIGUE; WEIGHT LOSS; heat intolerance; and excessive SWEATING.
| Excerpt | Relevance | Reference |
|---|---|---|
| " At the same time, the patient was diagnosed with hyperthyroidism and was given carbimazole and propranolol." | 7.80 | Slow carbamazepine clearance in a nonadherent Malay woman with epilepsy and thyrotoxicosis. ( Hui-Ping Khor, A; Lim, KS; Lo, YL; Ng, CC; Yeap, LL, 2014) |
| "The purpose of this study was to determine whether propranolol alone can improve mineral metabolic disorders in thyrotoxicosis." | 7.68 | Effect of propranolol on calcium, phosphorus, and magnesium metabolic disorders in Graves' disease. ( Chao, C; Wang, X; Wu, H, 1992) |
| "Preoperative management of treatment in thyrotoxicosis was investigated in a comparative study of carbimazole and propranolol in 41 consecutive patients collected during a 3-year period." | 7.67 | Preoperative treatment of thyrotoxicosis in developing countries: a comparative study of carbimazole and propranolol. ( Haddad, JF; Tibblin, S, 1988) |
| "Hypokalemia and hypophosphatemia are commonly encountered during paralysis in patients with thyrotoxic periodic paralysis (TPP) and may contribute to neuromuscular manifestations." | 5.31 | Propranolol rapidly reverses paralysis, hypokalemia, and hypophosphatemia in thyrotoxic periodic paralysis. ( Lin, SH; Lin, YF, 2001) |
| "The hypokalemia was treated aggressively with potassium without effect." | 5.29 | Thyrotoxic periodic paralysis terminated with intravenous propranolol. ( Hart, A; Shayne, P, 1994) |
| " In view of the increased enterohepatic circulation of thyroxine (T4) and triiodothyronine (T3) in thyrotoxicosis, and metabolic effects of konjac glucomannan in gastrointestinal system, we aimed to determine the activity of glucomannan in treatment of hyperthyroidism." | 5.12 | The use of konjac glucomannan to lower serum thyroid hormones in hyperthyroidism. ( Azezli, AD; Bayraktaroglu, T; Orhan, Y, 2007) |
| "We compared the efficacy of diltiazem and propranolol in a randomized, prospective, double-blind, crossover study in six patients with untreated thyrotoxicosis (mean age 31 yrs)." | 5.06 | Double-blind crossover trial of diltiazem versus propranolol in the management of thyrotoxic symptoms. ( Davies, TF; Fuster, V; Gelman, KM; Goldman, ME; Milner, MR; Phillips, RA, 1990) |
| " The patient was diagnosed as having Graves' thyrotoxicosis and thyrotoxic periodic paralysis (TPP) and was initially treated with propranolol and subsequently carbimazole." | 4.81 | Thyrotoxicosis and paraparesis in a young woman: case report and review of the literature. ( Aanderud, S; Bindoff, L; Bleskestad, IH; Mellgren, G, 2002) |
| " At the same time, the patient was diagnosed with hyperthyroidism and was given carbimazole and propranolol." | 3.80 | Slow carbamazepine clearance in a nonadherent Malay woman with epilepsy and thyrotoxicosis. ( Hui-Ping Khor, A; Lim, KS; Lo, YL; Ng, CC; Yeap, LL, 2014) |
| " The treatment of THPP consists of treating for hyperthyroidism plus propranolol." | 3.80 | [A case of thyreotoxic hypokalaemic periodic paralysis in a white male]. ( Eustatia-Rutten, CF; Kelderman, N; Kwak, AR; Piekaar, RS, 2014) |
| " A rat model of thyrotoxicosis was established by daily intraperitoneal injections of L-thyroxine (T(4), 100 μg/kg) for 4 weeks." | 3.78 | Irbesartan prevents myocardial remodeling in experimental thyrotoxic cardiomyopathy. ( Cho, KI; Choi, BG; Jeon, YK; Kang, JH; Kim, BH; Kim, IJ; Kim, JY; Kim, SJ; Kim, SM; Kim, SS; Kim, YK, 2012) |
| " Pertinent history revealed that he took drugs containing triiodothyronine (64 mug) and propranolol (40 mg) twice daily for weight reduction in the past month and discontinued these drugs 3 days before admission." | 3.75 | An unusual cause of thyrotoxic periodic paralysis: triiodothyronine-containing weight reducing agents. ( Chou, HK; Lin, SH; Tsao, YT, 2009) |
| " She had been undergoing treatment with methimazole for Graves's hyperthyroidism since the age of 34." | 3.73 | A case of transient central hyperthyroidism. ( Pishdad, GR; Pishdad, P; Sabzi, A, 2006) |
| " With the diagnosis of silent thyroiditis, he was treated with propranolol." | 3.70 | Silent thyroiditis after excision of a thymoma. ( Ishida, T; Murao, S; Sato, M; Takahara, J; Yoshinouchi, T, 1998) |
| "The present case describes a new and unusual variant of thyrotoxicosis: transient hyperthyroxinemia following acute and massive hemorrhage into a previously normal thyroid gland." | 3.69 | Toxic hematoma: an unusual and previously undescribed type of thyrotoxicosis. ( Skowsky, WR, 1995) |
| " We describe a 72-year-old lady who initially presented with episodic hypoglycemia secondary to an insulinoma that was controlled by diazoxide." | 3.69 | Relapse of medically treated insulinoma following the development of thyrotoxicosis: an assessment of potential mechanisms. ( Alberti, KG; Kendall-Taylor, P; Trajano, LR; Walker, M, 1994) |
| "The purpose of this study was to determine whether propranolol alone can improve mineral metabolic disorders in thyrotoxicosis." | 3.68 | Effect of propranolol on calcium, phosphorus, and magnesium metabolic disorders in Graves' disease. ( Chao, C; Wang, X; Wu, H, 1992) |
| " Authors diagnosed a rare type of thyrotoxicosis-triiodothyronine toxicosis+, which was only manifested by long-lasting supraventricular tachycardia without clinical state impairment." | 3.68 | [Long-term supraventricular tachycardia in a patient with triiodothyronine toxicosis]. ( Moszczyński, P; Słowiński, S; Zabówka, M, 1990) |
| "Thyrotoxicosis is the clinical manifestation of excess thyroid hormone action at the tissue level due to inappropriately high circulating thyroid hormone concentrations." | 2.61 | Thyrotoxicosis: Diagnosis and Management. ( Sharma, A; Stan, MN, 2019) |
| "Preoperative thyrotoxicosis is a potentially life-threatening condition that requires medical intervention before surgery." | 2.42 | Perioperative management of the thyrotoxic patient. ( Burch, HB; Langley, RW, 2003) |
| "We report a case of autoimmune thrombocytopenic purpura associated with hyperthyroidism in which the patient's thrombocytopenia and thyrotoxicosis resolved concomitantly." | 2.40 | Autoimmune thrombocytopenic purpura associated with hyperthyroidism in a single individual. ( Aggarwal, A; Doolittle, G, 1997) |
| "Down syndrome has long been associated with a variety of autoimmune conditions." | 2.38 | Hyperthyroidism and Down syndrome. ( Cheah, JS; Tambyah, PA, 1993) |
| "Periodic thyrotoxic paralysis is a genetic condition, rare in the West and in Caucasians." | 1.42 | Sudden flaccid paralysis. ( Ellis, O; Grover, K; Peshin, R; Tariq, M, 2015) |
| "Thyrotoxicosis is an uncommon cause of heart failure, and patients with heart failure rarely present with chylous ascites." | 1.36 | Chylous ascites as a manifestation of thyrotoxic cardiomyopathy in a patient with untreated Graves' disease. ( Chang, CT; Chen, CC; Hsieh, MH; Wang, TY, 2010) |
| "Thymic hyperplasia in the setting of Graves' disease was the diagnosis of exclusion." | 1.36 | Graves' disease and thymic hyperplasia: the relationship of thymic volume to thyroid function. ( Burman, KD; Carroll, NM; Devdhar, M; Popoveniuc, G; Sharma, M; Wartofsky, L; Wexler, JA, 2010) |
| "Monomorphic ventricular tachycardia (VT) is a unique manifestation of hyperthyroidism." | 1.36 | Repetitive monomorphic ventricular tachycardia as a manifestation of suboptimally treated thyrotoxicosis. ( Chandra, AB; Chandra, PA; Ghosh, J; Pednekar, M; Vallakati, A, 2010) |
| "Congenital thyrotoxicosis is a rare and potentially fatal illness." | 1.34 | An unusual cause of neonatal coagulopathy and liver disease. ( Dryden, C; Hunter, LE; Jackson, L; Simpson, JH, 2007) |
| "Thyrotoxic hypokalemic periodic paralysis (THPP) has been reported earlier in the Asian population." | 1.33 | An unusual cause of muscle weakness: a case report. ( Gandhi, M, 2006) |
| "Hypokalemia and hypophosphatemia are commonly encountered during paralysis in patients with thyrotoxic periodic paralysis (TPP) and may contribute to neuromuscular manifestations." | 1.31 | Propranolol rapidly reverses paralysis, hypokalemia, and hypophosphatemia in thyrotoxic periodic paralysis. ( Lin, SH; Lin, YF, 2001) |
| "The first patient had recurrence of thyrotoxicosis and paralysis after 16 months, whereas the second patient has remained symptom-free." | 1.31 | [Thyrotoxic periodic paralysis--an unusual complication of hyperthyroidism]. ( Aanderud, S; Bindoff, L; Bleskestad, IH; Holm, PI; Lien, EA; Mellgren, G, 2002) |
| "Prednisone was added after another episode of paralysis." | 1.30 | Normokalemic thyrotoxic periodic paralysis: a new therapeutic strategy. ( González-Treviño, O; Rosas-Guzmán, J, 1999) |
| "Although thyrotoxicosis is known to destabilize diabetes control, we can find no reports of it precipitating diabetic ketoacidosis." | 1.30 | Diabetic ketoacidosis precipitated by thyrotoxicosis. ( Bhattacharyya, A; Wiles, PG, 1999) |
| "The hypokalemia was treated aggressively with potassium without effect." | 1.29 | Thyrotoxic periodic paralysis terminated with intravenous propranolol. ( Hart, A; Shayne, P, 1994) |
| "Propranolol was again administered 6 hours after the surgery." | 1.29 | [Hyperthyroidism induced by molar pregnancy]. ( Banssillon, V; Besson, L; Doussin, JF; Laurent, V; Rondelet, B, 1993) |
| "Thyrotoxicosis resulted in cardiac hypertrophy (+20%) and tachycardia." | 1.29 | Heart rate variability in two models of cardiac hypertrophy in rats in relation to the new molecular phenotype. ( Carré, F; Chevalier, B; Coumel, P; Lessard, Y; Maison-Blanche, P; Mansier, P; Ollivier, L; Swynghedauw, B; Vicuna, R, 1994) |
| "The thyrotoxicosis was well manifested with disturbed carbohydrate tolerance and responded favourably to methizole treatment." | 1.28 | [Hypokalemic periodic paralysis in thyrotoxicosis]. ( Belovezhdov, N; Ilieva, K; Kalburova, F; Petrov, D, 1989) |
| "The chorea was severe and persisted after the patient was rendered euthyroid." | 1.27 | Persistent chorea as a manifestation of thyrotoxicosis. ( Hilton, DD; Javaid, A, 1988) |
| "When hypokalemia was discovered, potassium was administered, resulting in the development of hyperkalemia." | 1.27 | Thyrotoxic periodic paralysis. ( Bergeron, L; Sternbach, GL, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (12.87) | 18.7374 |
| 1990's | 28 (27.72) | 18.2507 |
| 2000's | 29 (28.71) | 29.6817 |
| 2010's | 29 (28.71) | 24.3611 |
| 2020's | 2 (1.98) | 2.80 |
| Authors | Studies |
|---|---|
| Sonowal, R | 1 |
| Anjali, A | 1 |
| Kumar, A | 1 |
| Builes-Montaño, CE | 1 |
| Rodriguez-Arrieta, LA | 1 |
| Román-González, A | 1 |
| Prieto-Saldarriaga, C | 1 |
| Alvarez-Payares, JC | 1 |
| Builes-Barrera, CA | 1 |
| Arango-Toro, CM | 1 |
| Asirvatham, AR | 1 |
| Balachandran, K | 1 |
| Mahadevan, S | 1 |
| Balasubramanian, S | 1 |
| Singhai, P | 1 |
| Krishnan, S | 1 |
| Patil, VU | 1 |
| Samuels, SL | 1 |
| Namoc, SM | 1 |
| Bauer, AJ | 1 |
| Xue, J | 1 |
| Zhang, L | 1 |
| Qin, Z | 1 |
| Li, R | 1 |
| Wang, Y | 1 |
| Zhu, K | 1 |
| Li, X | 1 |
| Gao, X | 1 |
| Zhang, J | 1 |
| Silverman, E | 1 |
| Haber, LA | 1 |
| Geha, RM | 1 |
| Ronan, GP | 1 |
| Ronan, N | 1 |
| McGettigan, S | 1 |
| Browne, G | 1 |
| Sharma, A | 1 |
| Stan, MN | 1 |
| Al-Refaie, N | 1 |
| Appiah, S | 1 |
| Mandal, AKJ | 1 |
| Missouris, CG | 1 |
| Cope, TE | 1 |
| Samaraweera, AP | 1 |
| Burn, DJ | 1 |
| Yeap, LL | 1 |
| Lim, KS | 1 |
| Ng, CC | 1 |
| Hui-Ping Khor, A | 1 |
| Lo, YL | 1 |
| Bisschop, PH | 1 |
| van Trotsenburg, AS | 1 |
| Matta, A | 1 |
| Koppala, J | 1 |
| Gossman, W | 1 |
| Munir, A | 1 |
| Piekaar, RS | 1 |
| Kwak, AR | 1 |
| Kelderman, N | 1 |
| Eustatia-Rutten, CF | 1 |
| Chalasani, S | 1 |
| Benson, KA | 1 |
| Tariq, M | 1 |
| Peshin, R | 1 |
| Ellis, O | 1 |
| Grover, K | 1 |
| Correia, MF | 1 |
| Maria, AT | 1 |
| Prado, S | 1 |
| Limbert, C | 1 |
| Siddiqui, FA | 1 |
| Sheikh, A | 1 |
| Lussier, D | 1 |
| Herd, A | 1 |
| Chou, HK | 1 |
| Tsao, YT | 1 |
| Lin, SH | 2 |
| Teague, E | 1 |
| O'Brien, CJ | 1 |
| Campbell, NP | 1 |
| Piñar, D | 1 |
| Boix, E | 1 |
| Meana, JA | 1 |
| Herrero, J | 1 |
| Lodha, A | 1 |
| Haran, M | 1 |
| Frankel, R | 1 |
| Shani, J | 1 |
| Tran, HA | 2 |
| Barski, L | 1 |
| Nevzorov, R | 1 |
| Lotkowitz, A | 1 |
| Shleyfer, E | 1 |
| Liel, Y | 1 |
| Hsieh, MH | 1 |
| Chen, CC | 1 |
| Wang, TY | 1 |
| Chang, CT | 1 |
| Majlesi, N | 1 |
| Greller, HA | 1 |
| McGuigan, MA | 1 |
| Caraccio, T | 1 |
| Su, MK | 1 |
| Chan, GM | 1 |
| Popoveniuc, G | 1 |
| Sharma, M | 1 |
| Devdhar, M | 1 |
| Wexler, JA | 1 |
| Carroll, NM | 1 |
| Wartofsky, L | 1 |
| Burman, KD | 1 |
| Mathew, B | 1 |
| Devasia, AJ | 1 |
| Ayyar, V | 1 |
| Thyagaraj, V | 1 |
| Francis, GA | 1 |
| Wintergerst, KA | 1 |
| Rogers, ES | 1 |
| Foster, MB | 1 |
| Chandra, PA | 1 |
| Vallakati, A | 1 |
| Chandra, AB | 1 |
| Pednekar, M | 1 |
| Ghosh, J | 1 |
| Kim, BH | 2 |
| Cho, KI | 1 |
| Kim, SM | 1 |
| Kim, JY | 1 |
| Choi, BG | 2 |
| Kang, JH | 2 |
| Jeon, YK | 2 |
| Kim, SS | 2 |
| Kim, SJ | 1 |
| Kim, YK | 2 |
| Kim, IJ | 2 |
| Oh, SB | 1 |
| Ahn, J | 1 |
| Oh, MY | 1 |
| Kim, JH | 1 |
| Park, G | 1 |
| Kim, SY | 1 |
| Bae, HY | 1 |
| Langley, RW | 1 |
| Burch, HB | 1 |
| Chan, L | 1 |
| Tassone, H | 1 |
| Moulin, A | 1 |
| Henderson, SO | 1 |
| Lionet, A | 1 |
| Barsumau, J | 1 |
| Azar, R | 1 |
| Vilches, AR | 1 |
| Lerman, J | 1 |
| Akar, S | 1 |
| Comlekci, A | 1 |
| Birlik, M | 1 |
| Onen, F | 1 |
| Sari, I | 1 |
| Gurler, O | 1 |
| Bekis, R | 1 |
| Akkoc, N | 1 |
| Iwatani, Y | 1 |
| Al-Jubouri, MA | 1 |
| Inkster, GD | 1 |
| Nee, PA | 1 |
| Andrews, FJ | 1 |
| Gandhi, M | 1 |
| Pishdad, GR | 1 |
| Pishdad, P | 1 |
| Sabzi, A | 1 |
| Balami, J | 1 |
| Jones, H | 1 |
| Newey, P | 1 |
| Seymour, J | 1 |
| Yu, TS | 1 |
| Tseng, CF | 1 |
| Chuang, YY | 1 |
| Yeung, LK | 1 |
| Lu, KC | 1 |
| Dryden, C | 1 |
| Simpson, JH | 1 |
| Hunter, LE | 1 |
| Jackson, L | 1 |
| Erturk, E | 1 |
| Bostan, H | 1 |
| Geze, S | 1 |
| Saracoglu, S | 1 |
| Erciyes, N | 1 |
| Eroglu, A | 1 |
| Azezli, AD | 1 |
| Bayraktaroglu, T | 1 |
| Orhan, Y | 1 |
| Skowsky, WR | 1 |
| Chia, BL | 1 |
| Lee, KH | 1 |
| Cheah, JS | 2 |
| Ko, GT | 1 |
| Chow, CC | 2 |
| Sanderson, JE | 1 |
| Yeung, VT | 1 |
| Cockram, CS | 1 |
| Agarwal, AK | 1 |
| Wadhwa, S | 1 |
| Wali, M | 1 |
| Walker, M | 1 |
| Trajano, LR | 1 |
| Alberti, KG | 1 |
| Kendall-Taylor, P | 1 |
| Shayne, P | 1 |
| Hart, A | 1 |
| Carré, F | 1 |
| Maison-Blanche, P | 1 |
| Ollivier, L | 1 |
| Mansier, P | 1 |
| Chevalier, B | 1 |
| Vicuna, R | 1 |
| Lessard, Y | 1 |
| Coumel, P | 1 |
| Swynghedauw, B | 1 |
| Tambyah, PA | 1 |
| Laurent, V | 1 |
| Besson, L | 1 |
| Doussin, JF | 1 |
| Rondelet, B | 1 |
| Banssillon, V | 1 |
| van Dam, GM | 1 |
| Reisman, Y | 1 |
| van Wieringen, K | 1 |
| Aggarwal, A | 1 |
| Doolittle, G | 1 |
| Murao, S | 1 |
| Yoshinouchi, T | 1 |
| Sato, M | 1 |
| Ishida, T | 1 |
| Takahara, J | 1 |
| González-Treviño, O | 1 |
| Rosas-Guzmán, J | 1 |
| Rink, T | 1 |
| Wieg, C | 1 |
| Schroth, HJ | 1 |
| Helisch, A | 1 |
| Bertram, U | 1 |
| Hack, JB | 1 |
| Leviss, JA | 1 |
| Nelson, LS | 1 |
| Hoffman, RS | 1 |
| Bhattacharyya, A | 1 |
| Wiles, PG | 1 |
| Alagöl, F | 1 |
| Tanakol, R | 1 |
| Boztepe, H | 1 |
| Kapran, Y | 1 |
| Terzioglu, T | 1 |
| Dizdaroglu, F | 1 |
| Morelli, S | 1 |
| Gurgo, AM | 1 |
| Martocchia, A | 1 |
| Falaschi, P | 1 |
| Birkhahn, RH | 1 |
| Gaeta, TJ | 1 |
| Melniker, L | 1 |
| Shamrakov, O | 1 |
| Berner, Y | 1 |
| Lin, YF | 1 |
| Smith, C | 1 |
| Thomsett, M | 1 |
| Choong, C | 1 |
| Rodda, C | 1 |
| McIntyre, HD | 1 |
| Cotterill, AM | 1 |
| Kumpusalo, E | 1 |
| Mellgren, G | 2 |
| Bleskestad, IH | 2 |
| Aanderud, S | 2 |
| Bindoff, L | 2 |
| Zumo, LA | 1 |
| Terzian, C | 1 |
| Brannan, T | 1 |
| Holm, PI | 1 |
| Lien, EA | 1 |
| Duckworth, J | 1 |
| Johnson, RB | 1 |
| Hoque, MN | 1 |
| Ikeda, T | 1 |
| Ochi, H | 1 |
| Ohtani, I | 1 |
| Fujiyama, K | 1 |
| Hoshino, T | 1 |
| Tanaka, Y | 1 |
| Takeuchi, T | 1 |
| Mashiba, H | 1 |
| Wang, X | 1 |
| Wu, H | 1 |
| Chao, C | 1 |
| Lee, S | 1 |
| Wing, YK | 1 |
| Leung, CM | 1 |
| Chiu, H | 1 |
| Chen, CN | 1 |
| Mengistu, M | 1 |
| Lebedeva, EA | 1 |
| Sokolov, EI | 1 |
| Zaev, AP | 1 |
| Ol'kha, RP | 1 |
| Zhizhina, SA | 1 |
| Khovanskaia, TP | 1 |
| Słowiński, S | 1 |
| Moszczyński, P | 1 |
| Zabówka, M | 1 |
| Milner, MR | 1 |
| Gelman, KM | 1 |
| Phillips, RA | 1 |
| Fuster, V | 1 |
| Davies, TF | 1 |
| Goldman, ME | 1 |
| Wang, YT | 1 |
| Poh, SC | 1 |
| Wang, XB | 1 |
| Chao, CS | 1 |
| Wu, HW | 1 |
| Kalburova, F | 1 |
| Petrov, D | 1 |
| Ilieva, K | 1 |
| Belovezhdov, N | 1 |
| Lim, BH | 1 |
| Raman, S | 1 |
| Sivanesaratnam, V | 1 |
| Ngan, A | 1 |
| Mandel, SH | 1 |
| Magnusson, AR | 1 |
| Burton, BT | 1 |
| Swanson, JR | 1 |
| LaFranchi, SH | 1 |
| Marmon, L | 1 |
| Au, FC | 1 |
| Gelfand, RA | 1 |
| Hutchinson-Williams, KA | 1 |
| Bonde, AA | 1 |
| Castellino, P | 1 |
| Sherwin, RS | 1 |
| Regan, WM | 1 |
| Haddad, JF | 1 |
| Tibblin, S | 1 |
| Javaid, A | 1 |
| Hilton, DD | 1 |
| Bergeron, L | 1 |
| Sternbach, GL | 1 |
| Coates, JT | 1 |
| Mirick, MJ | 1 |
| Rubino, FJ | 1 |
| Kamlana, SH | 1 |
| Holms, L | 1 |
11 reviews available for propranolol and Thyrotoxicosis
| Article | Year |
|---|---|
Neonatal Thyrotoxicosis.
Topics: Adrenergic beta-Antagonists; Antithyroid Agents; Female; Fetal Diseases; Graves Disease; Humans; Hyp | 2018 |
Thyrotoxicosis: Diagnosis and Management.
Topics: Adrenergic beta-Antagonists; Glucocorticoids; Humans; Propranolol; Thyroid Gland; Thyrotoxicosis | 2019 |
Perioperative management of the thyrotoxic patient.
Topics: Adrenergic beta-Antagonists; Antithyroid Agents; Graves Disease; Humans; Iodine; Iopanoic Acid; Peri | 2003 |
The pitfalls of potassium replacement in thyrotoxic periodic paralysis: a case report and review of the literature.
Topics: Adult; Anti-Arrhythmia Agents; Emergency Medical Services; Humans; Hyperkalemia; Hyperthyroidism; Hy | 2004 |
[T3 toxicosis].
Topics: Adrenergic beta-Antagonists; Antithyroid Agents; Diagnosis, Differential; Goiter, Nodular; Graves Di | 2006 |
Hyperthyroidism and Down syndrome.
Topics: Adolescent; Adult; Carbimazole; Down Syndrome; Drug Therapy, Combination; HLA-B Antigens; Humans; Hy | 1993 |
Hypokalaemic thyrotoxic periodic paralysis: case report and review of an Oriental syndrome.
Topics: Adrenergic beta-Antagonists; Adult; Anti-Inflammatory Agents; Antithyroid Agents; Humans; Hypokalemi | 1996 |
Autoimmune thrombocytopenic purpura associated with hyperthyroidism in a single individual.
Topics: Adrenergic beta-Antagonists; Female; gamma-Globulins; Glucocorticoids; Humans; Hyperthyroidism; Inje | 1997 |
Anaplastic thyroid cancer with transient thyrotoxicosis: case report and literature review.
Topics: Biopsy; Carcinoma; Fatal Outcome; Female; Goiter, Nodular; Humans; Middle Aged; Propranolol; Thyroid | 1999 |
Thyrotoxicosis, unstable angina and normal coronary angiogram.
Topics: Angina, Unstable; Anti-Arrhythmia Agents; Chest Pain; Combined Modality Therapy; Coronary Angiograph | 1999 |
Thyrotoxicosis and paraparesis in a young woman: case report and review of the literature.
Topics: Adrenergic beta-Antagonists; Adult; Antithyroid Agents; Carbimazole; Female; Graves Disease; Humans; | 2002 |
3 trials available for propranolol and Thyrotoxicosis
| Article | Year |
|---|---|
The use of konjac glucomannan to lower serum thyroid hormones in hyperthyroidism.
Topics: Adult; Antithyroid Agents; Drug Therapy, Combination; Female; Graves Disease; Humans; Hyperthyroidis | 2007 |
[Treatment of thyrotoxicosis with anaprilin and mercasolil].
Topics: Adolescent; Adult; Drug Therapy, Combination; Female; Humans; Male; Methimazole; Middle Aged; Propra | 1991 |
Double-blind crossover trial of diltiazem versus propranolol in the management of thyrotoxic symptoms.
Topics: Administration, Oral; Adult; Blood Pressure; Diltiazem; Double-Blind Method; Female; Heart Rate; Hum | 1990 |
87 other studies available for propranolol and Thyrotoxicosis
| Article | Year |
|---|---|
Neonatal Thyrotoxicosis Co-existing With Early Onset Sepsis.
Topics: Electrocardiography; Female; Humans; Infant; Intensive Care Units, Neonatal; Methimazole; Neonatal S | 2021 |
Therapeutic plasmapheresis for the treatment of thyrotoxicosis: A retrospective multi-center study.
Topics: Adolescent; Adult; Child; Female; Humans; Male; Middle Aged; Plasmapheresis; Propranolol; Retrospect | 2021 |
Lingual dyskinesia in hyperthyroidism.
Topics: Adrenergic beta-Antagonists; Adult; Antithyroid Agents; Carbimazole; Dyskinesias; Female; Humans; Hy | 2017 |
Thyrotoxic Channelopathies.
Topics: Adult; Anti-Arrhythmia Agents; Antithyroid Agents; Atrial Fibrillation; Carbimazole; Channelopathies | 2017 |
No obvious sympathetic excitation after massive levothyroxine overdose: A case report.
Topics: Adrenergic beta-Antagonists; Adult; Drug Overdose; Female; Humans; Propranolol; Renal Dialysis; Symp | 2018 |
Lift Then Shift: Thyrotoxic Periodic Paralysis.
Topics: Adrenergic beta-Antagonists; Adult; Antithyroid Agents; Humans; Hypokalemic Periodic Paralysis; Male | 2019 |
Serotonin syndrome unmasking thyrotoxicosis.
Topics: 3,4-Methylenedioxyamphetamine; Adult; Aftercare; Anti-Arrhythmia Agents; Antithyroid Agents; Carbima | 2019 |
Don't Trip Over the Trop: An Unusual Presentation of Thyrotoxic Periodic Paralysis.
Topics: Adrenergic beta-Antagonists; Adult; Antithyroid Agents; Electrocardiography; Humans; Hypokalemic Per | 2019 |
Thyrotoxic periodic paralysis: correct hypokalemia with caution.
Topics: Adrenergic beta-Antagonists; Adult; Antithyroid Agents; Graves Disease; Humans; Hypokalemia; Male; M | 2013 |
Slow carbamazepine clearance in a nonadherent Malay woman with epilepsy and thyrotoxicosis.
Topics: Adult; Anticonvulsants; Antithyroid Agents; Carbamazepine; Carbimazole; Dose-Response Relationship, | 2014 |
Images in clinical medicine. Neonatal thyrotoxicosis.
Topics: Adult; Apgar Score; Eyelids; Female; Fetal Growth Retardation; Graves Disease; Heart Rate, Fetal; Hu | 2014 |
Thyrotoxic hypokalaemic periodic paralysis: a rare presentation of Graves' disease in a Hispanic patient.
Topics: Adult; Diagnosis, Differential; Graves Disease; Hispanic or Latino; Humans; Hypokalemia; Hypokalemic | 2014 |
Thyrotoxic periodic paralysis: an endocrine cause of paraparesis.
Topics: Adult; Antithyroid Agents; Graves Disease; Humans; Hyperthyroidism; Hypokalemic Periodic Paralysis; | 2014 |
[A case of thyreotoxic hypokalaemic periodic paralysis in a white male].
Topics: Adult; Antithyroid Agents; Graves Disease; Humans; Hyperthyroidism; Hypokalemic Periodic Paralysis; | 2014 |
Lithium-induced thyrotoxicosis in a patient with treatment-resistant bipolar type I affective disorder.
Topics: Adrenergic beta-Antagonists; Antimanic Agents; Bipolar Disorder; Drug Resistance; Female; Humans; Li | 2014 |
Sudden flaccid paralysis.
Topics: Adult; Antithyroid Agents; Arrhythmias, Cardiac; Brugada Syndrome; Carbimazole; Cardiac Conduction S | 2015 |
Neonatal thyrotoxicosis caused by maternal autoimmune hyperthyroidism.
Topics: Antithyroid Agents; Female; Graves Disease; Humans; Infant, Newborn; Iodides; Male; Methimazole; Pre | 2015 |
Muscle paralysis in thyrotoxicosis.
Topics: Adrenergic beta-Antagonists; Adult; Antithyroid Agents; Carbimazole; Humans; Hypokalemic Periodic Pa | 2015 |
A Diagnostic Challenge: Acute Flaccid Paralysis.
Topics: Acute Disease; Adult; Drug Therapy, Combination; Emergency Service, Hospital; Follow-Up Studies; Hum | 2017 |
An unusual cause of thyrotoxic periodic paralysis: triiodothyronine-containing weight reducing agents.
Topics: Adult; Humans; Hypokalemic Periodic Paralysis; Male; Propranolol; Substance Withdrawal Syndrome; Thy | 2009 |
Pericardial effusion and tamponade complicating treated graves' thyrotoxocosis.
Topics: Adult; Antithyroid Agents; Carbimazole; Cardiac Tamponade; Female; Humans; Pericardial Effusion; Pro | 2009 |
Sunitinib-induced thyrotoxicosis.
Topics: Aged; Antineoplastic Agents; Carbimazole; Carcinoma, Renal Cell; Humans; Indoles; Kidney Neoplasms; | 2009 |
Thyrotoxicosis causing arterial and venous thrombosis.
Topics: Anticoagulants; Antithyroid Agents; Blood Coagulation; Humans; Infarction, Middle Cerebral Artery; M | 2009 |
The swinging thyroid in hepatitis C infection and interferon therapy.
Topics: Antiviral Agents; Autoantibodies; Drug Therapy, Combination; Hepatitis C; Humans; Interferon alpha-2 | 2010 |
Thyrotoxic hypokalemic periodic paralysis as the presenting symptom in a young Ashkenazi Jewish man.
Topics: Adult; Antihypertensive Agents; Antithyroid Agents; Emergencies; Follow-Up Studies; Genetic Predispo | 2009 |
Chylous ascites as a manifestation of thyrotoxic cardiomyopathy in a patient with untreated Graves' disease.
Topics: Cardiomyopathies; Chylous Ascites; Diuretics; Female; Graves Disease; Heart Failure; Humans; Propran | 2010 |
Thyroid storm after pediatric levothyroxine ingestion.
Topics: Adrenergic beta-Antagonists; Child, Preschool; Drug Overdose; Female; Humans; Propranolol; Thyrotoxi | 2010 |
Graves' disease and thymic hyperplasia: the relationship of thymic volume to thyroid function.
Topics: Adrenergic beta-Antagonists; Adult; Anti-Inflammatory Agents; Antithyroid Agents; Calcium Channel Bl | 2010 |
Thyrotoxicosis presenting as acute bulbar palsy.
Topics: Acute Disease; Adrenergic beta-Antagonists; Antithyroid Agents; Bulbar Palsy, Progressive; Carbimazo | 2011 |
Hyperthyroidism presenting with hyperglycemia in an adolescent female.
Topics: Adolescent; Adrenergic beta-Antagonists; Antithyroid Agents; Blood Glucose; Female; Graves Disease; | 2011 |
Repetitive monomorphic ventricular tachycardia as a manifestation of suboptimally treated thyrotoxicosis.
Topics: Adrenergic beta-Antagonists; Adult; Antithyroid Agents; Humans; Male; Methimazole; Propranolol; Tach | 2010 |
Irbesartan prevents myocardial remodeling in experimental thyrotoxic cardiomyopathy.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Biphenyl Compounds; Cardiomyopathies; Echocardiogr | 2012 |
Thyrotoxic periodic paralysis associated with transient thyrotoxicosis due to painless thyroiditis.
Topics: Administration, Oral; Adult; Anti-Arrhythmia Agents; Humans; Hypokalemic Periodic Paralysis; Male; O | 2012 |
Thyrotoxic periodic paralysis with Graves' disease leading to the discovery of a hidden nonclassic 11β hydroxylase deficiency.
Topics: Adrenal Hyperplasia, Congenital; Diagnosis, Differential; Drug Therapy, Combination; Graves Disease; | 2013 |
Gestational transient thyrotoxicosis.
Topics: Adult; Anti-Arrhythmia Agents; Antiemetics; Antithyroid Agents; Diagnosis, Differential; Emergency M | 2003 |
[Thyrotoxic hypokalaemic periodic paralysis in a Caucasian male].
Topics: Adrenergic beta-Antagonists; Adult; Antithyroid Agents; Asian People; Carbimazole; Genetic Predispos | 2004 |
[First degree atrio-ventricular block in acute thyrotoxicosis].
Topics: Acute Disease; Adult; Anti-Arrhythmia Agents; Antithyroid Agents; Female; Heart Block; Humans; Hyper | 2004 |
Thyrotoxic periodic paralysis in a Turkish male; the recurrence of the attack after radioiodine treatment.
Topics: Adrenergic beta-Antagonists; Adult; Humans; Hyperthyroidism; Hypokalemia; Iodine Radioisotopes; Male | 2005 |
Thyrotoxic periodic paralysis.
Topics: Carbimazole; Humans; Hyperthyroidism; Iodine Radioisotopes; Male; Paralysis; Periodicity; Propranolo | 2005 |
Thyrotoxicosis presenting as hypokalaemic paralysis and hyperlactataemia in an oriental man.
Topics: Administration, Oral; Adult; Asian People; Diagnosis, Differential; Humans; Hypokalemic Periodic Par | 2006 |
An unusual cause of muscle weakness: a case report.
Topics: Adrenergic beta-Antagonists; Antithyroid Agents; Asian People; Humans; Hypokalemic Periodic Paralysi | 2006 |
A case of transient central hyperthyroidism.
Topics: Anti-Anxiety Agents; Chronic Disease; Female; Follow-Up Studies; Humans; Hyperthyroidism; Hypothyroi | 2006 |
Thyrotoxic hypokalaemic periodic paralysis.
Topics: Adult; Antithyroid Agents; Carbimazole; Humans; Hypokalemic Periodic Paralysis; Male; Propranolol; T | 2006 |
Potassium chloride supplementation alone may not improve hypokalemia in thyrotoxic hypokalemic periodic paralysis.
Topics: Adrenergic beta-Antagonists; Adult; Drug Therapy, Combination; Humans; Hypokalemic Periodic Paralysi | 2007 |
An unusual cause of neonatal coagulopathy and liver disease.
Topics: Antithyroid Agents; Carbimazole; Diagnosis, Differential; Drug Therapy, Combination; Female; Follow- | 2007 |
Total intravenous anesthesia for evacuation of a hydatidiform mole and termination of pregnancy in a patient with thyrotoxicosis.
Topics: Abortion, Induced; Adrenergic beta-Antagonists; Adult; Anesthesia, Intravenous; Anesthetics, Intrave | 2007 |
Toxic hematoma: an unusual and previously undescribed type of thyrotoxicosis.
Topics: Aged; Antithyroid Agents; Female; Hematoma; Humans; Propranolol; Thyroid Diseases; Thyroid Function | 1995 |
Sino-atrial Wenckebach conduction in thyrotoxic periodic paralysis: a case report.
Topics: Adult; Carbimazole; Drug Therapy, Combination; Electrocardiography; Humans; Hypokalemia; Infusions, | 1995 |
Should beta-blocking agents be used in thyrotoxic heart disease?
Topics: Adult; Fatal Outcome; Heart Failure; Humans; Male; Middle Aged; Propranolol; Thyrotoxicosis | 1995 |
Hypokalaemic periodic paralysis associated with thyrotoxicosis.
Topics: Humans; Hypokalemia; Paralysis; Periodicity; Propranolol; Thyrotoxicosis | 1994 |
Relapse of medically treated insulinoma following the development of thyrotoxicosis: an assessment of potential mechanisms.
Topics: Aged; C-Peptide; Diazoxide; Female; Humans; Hypoglycemia; Insulin; Insulin Resistance; Insulinoma; P | 1994 |
Thyrotoxic periodic paralysis terminated with intravenous propranolol.
Topics: Adult; Drug Therapy, Combination; Electrocardiography; Humans; Hypokalemia; Male; Paralysis; Potassi | 1994 |
Heart rate variability in two models of cardiac hypertrophy in rats in relation to the new molecular phenotype.
Topics: Analysis of Variance; Animals; Aortic Valve Stenosis; Atropine; Cardiomegaly; Electrocardiography, A | 1994 |
[Hyperthyroidism induced by molar pregnancy].
Topics: Adult; Anesthesia, General; Chorionic Gonadotropin; Female; Humans; Hydatidiform Mole; Hyperthyroidi | 1993 |
Silent thyroiditis after excision of a thymoma.
Topics: Humans; Male; Middle Aged; Postoperative Complications; Propranolol; Thymoma; Thymus Neoplasms; Thyr | 1998 |
Normokalemic thyrotoxic periodic paralysis: a new therapeutic strategy.
Topics: Adult; Drug Therapy, Combination; Humans; Male; Methimazole; Paralysis; Potassium; Prednisone; Propr | 1999 |
[Hyperthyroidism in a premature infant due to transplacental passage of maternal thyrotropin receptor antibodies].
Topics: Adult; Anti-Arrhythmia Agents; Antithyroid Agents; Autoantibodies; Carbimazole; Cardiotonic Agents; | 1999 |
Severe symptoms following a massive intentional L-thyroxine ingestion.
Topics: Adult; Antidotes; Body Weight; Charcoal; Diazepam; Haloperidol; Humans; Intubation, Intratracheal; M | 1999 |
Diabetic ketoacidosis precipitated by thyrotoxicosis.
Topics: Adult; Anti-Arrhythmia Agents; Antithyroid Agents; Carbimazole; Diabetic Ketoacidosis; Female; Human | 1999 |
Thyrotoxic periodic paralysis and intravenous propranolol in the emergency setting.
Topics: Adult; Anti-Arrhythmia Agents; Electrocardiography; Humans; Hypokalemia; Injections, Intravenous; Ma | 2000 |
Response of elderly women with thyrotoxicosis to treatment for tardive dyskinesia.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspir | 1999 |
Propranolol rapidly reverses paralysis, hypokalemia, and hypophosphatemia in thyrotoxic periodic paralysis.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Humans; Hypokalemic Periodic Paralysis; Hy | 2001 |
Congenital thyrotoxicosis in premature infants.
Topics: Antithyroid Agents; Autoantibodies; Carbimazole; Female; Fetal Blood; Fetal Growth Retardation; Grav | 2001 |
[Abdominal pain in a young woman].
Topics: Abdominal Pain; Adrenergic beta-Antagonists; Adult; Female; Humans; Propranolol; Skiing; Syncope; Th | 2000 |
Thyrotoxic hypokalemic periodic paralysis in a Hispanic male.
Topics: Adult; Follow-Up Studies; Graves Disease; Hispanic or Latino; Humans; Hypokalemia; Iodine; Male; Par | 2002 |
[Thyrotoxic periodic paralysis--an unusual complication of hyperthyroidism].
Topics: Adrenergic beta-Antagonists; Adult; Antithyroid Agents; Carbimazole; Electrocardiography; Female; Gr | 2002 |
Correct dosage?
Topics: Humans; Hydrocortisone; Propranolol; Thyrotoxicosis | 2002 |
Thyrotoxic periodic paralysis in a Saudi Arab.
Topics: Adult; Graves Disease; Humans; Infusions, Intravenous; Male; Paralysis; Potassium; Propranolol; Prop | 1992 |
Adrenergic mechanism in hyperketonemia in thyrotoxic and starved rats.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Animals; Blood Glucose; Fatty Acids, Nonesterified; Glucagon; | 1992 |
Effect of propranolol on calcium, phosphorus, and magnesium metabolic disorders in Graves' disease.
Topics: Adolescent; Adult; Calcium; Female; Graves Disease; Humans; Magnesium; Male; Metabolic Diseases; Mid | 1992 |
Mania secondary to thyrotoxicosis.
Topics: Adult; Bipolar Disorder; Drug Therapy, Combination; Female; Humans; Neurocognitive Disorders; Propra | 1991 |
Thyrotoxicosis in an Ethiopian teaching hospital.
Topics: Adolescent; Adult; Aged; Ethiopia; Female; Hospitals, Teaching; Humans; Male; Middle Aged; Outpatien | 1991 |
[Hemodynamics and its control in patients with thyrotoxicosis and in healthy persons according to the data of anapriline and graded exercise tests].
Topics: Adult; Catecholamines; Electrocardiography; Exercise Test; Female; Hemodynamics; Humans; Male; Propr | 1990 |
[Long-term supraventricular tachycardia in a patient with triiodothyronine toxicosis].
Topics: Adult; Drug Therapy, Combination; Electrocardiography; Female; Humans; Methimazole; Propranolol; Tac | 1990 |
Lung function and respiratory muscle strength after propranolol in thyrotoxicosis.
Topics: Adolescent; Adult; Aged; Antithyroid Agents; Child; Female; Forced Expiratory Volume; Humans; Lung; | 1986 |
[Hypercalcemia and hyperphosphatemia in thyrotoxoicosis and the therapeutic effect of propranolol].
Topics: Adolescent; Adult; Calcium; Female; Humans; Hypercalcemia; Male; Middle Aged; Phosphorus; Propranolo | 1989 |
[Hypokalemic periodic paralysis in thyrotoxicosis].
Topics: Adult; Drug Therapy, Combination; Humans; Hypokalemia; Male; Methimazole; Paralyses, Familial Period | 1989 |
Thyrotoxicosis in pregnancy--a six year review.
Topics: Adult; Carbimazole; Female; Humans; Malaysia; Pregnancy; Pregnancy Complications; Pregnancy Outcome; | 1989 |
Massive levothyroxine ingestion. Conservative management.
Topics: Charcoal; Child, Preschool; Female; Humans; Propranolol; Thyrotoxicosis; Thyroxine | 1989 |
The preoperative use of iodine solution in thyrotoxic patients prepared with propranolol. Is it necessary?
Topics: Administration, Oral; Adolescent; Adult; Drug Therapy, Combination; Female; Hemoglobins; Hemostasis, | 1989 |
Catabolic effects of thyroid hormone excess: the contribution of adrenergic activity to hypermetabolism and protein breakdown.
Topics: Adrenergic beta-Antagonists; Adrenergic Fibers; Adult; Body Weight; Energy Intake; Energy Metabolism | 1987 |
Thyrotoxicosis manifested as mania.
Topics: Adult; Bipolar Disorder; Commitment of Mentally Ill; Humans; Iodine Radioisotopes; Male; Propranolol | 1988 |
Preoperative treatment of thyrotoxicosis in developing countries: a comparative study of carbimazole and propranolol.
Topics: Adolescent; Adult; Carbimazole; Child; Developing Countries; Female; Humans; Male; Middle Aged; Preo | 1988 |
Persistent chorea as a manifestation of thyrotoxicosis.
Topics: Adolescent; Carbimazole; Chlorpromazine; Chorea; Female; Haloperidol; Humans; Propranolol; Thyrotoxi | 1988 |
Thyrotoxic periodic paralysis.
Topics: Adult; Humans; Hyperkalemia; Hypokalemia; Male; Methimazole; Paralyses, Familial Periodic; Potassium | 1988 |
Thyrotoxic periodic paralysis with relapse during the euthyroid state.
Topics: Adult; Humans; Hypokalemia; Male; Methimazole; Paralysis; Periodicity; Propranolol; Recurrence; Thyr | 1987 |
Paranoid reaction and underlying thyrotoxicosis.
Topics: Adult; Carbimazole; Chlorpromazine; Drug Therapy, Combination; Female; Humans; Paranoid Disorders; P | 1986 |